Earnings NewsHealthcareAlbireo Pharma GAAP EPS of -$0.57, revenue of $32.52MMar. 01, 2022 8:41 AM ETAlbireo Pharma, Inc. (ALBO) StockBy: Deepa Sarvaiya, SA News Editor Albireo Pharma press release (NASDAQ:ALBO): Q4 GAAP EPS of -$0.57. Revenue of $32.52M (vs $2.72M in Q420). Recommended For YouCommentsNewestPublishHave a tip? Submit confidentially to our News team. Found a factual error? Report here.More Trending NewsCatalyst Watch: Intel's AI event, Oracle earnings and CAVA IPO lockup expirationElectric vehicles 2024 and beyond: Why Tesla, BYD and Rivian may lap the fieldGoogle's Gemini will make for a solid 2024: CitiRecord-breaking U.S. supply is weighing on the global oil marketRobinhood tops financial gainers, RenaissanceRe falls the most: Weekly roundupSee More »Related StocksSymbolLast Price% ChgALBO--Albireo Pharma, Inc.MIRM--Mirum Pharmaceuticals, Inc.IPSEF--Ipsen S.A.ADXN--Addex Therapeutics LtdCMMB--Chemomab Therapeutics Ltd.CompareTrending AnalysisTrending News